HedgePath Pharmaceuticals, Inc. (HPPI)
OTOTC · Common · CUSIP 42278K102
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for HPPI and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
42278K102 (prev. 202739108 )
Market Cap
Micro Cap · $2 Million
Previous Symbol
CBTEQ (changed 8/19/2013)
Previous Name
Commonwealth Biotechnologies, Inc.
Business: HedgePath Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer.
Notes: Name/Symbol/CUSIP Change. By virtue of the Merger & without any action on the part of the holder thereof, each share of Corporation Common stock issued and outstanding immediately prior thereto shall be changed and converted automatically into an equal amount of fully paid & nonassessable shares of Subsidiary Common Stock. Plan of Bankruptcy effective 4/15/2013.

Company Contact

CEO
Nicholas J. Virca
CFO
Garrison J. Hasara
Headquarters
324 S. Hyde Park Avenue Ste. 350, Tampa, FL 33606
Phone
813-864-2559
Fax
813-527-0500
Investor Relations
813-527-0500 · ghasara@hedgepathpharma.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »